Meeting Details

The 6th Annual General Meeting of Piramal Pharma Limited was held on Thursday, 30th July, 2026 at 3:00 p.m. (IST) through Video Conferencing/Other Audio Visual Means. The meeting was chaired by Ms. Nandini Piramal, Chairperson of the Company. The meeting concluded at 4:26 p.m.

The requisite quorum was present. Live proceedings were webcast on the e-voting website of National Securities Depository Limited (NSDL).

Voting Process

Remote e-voting commenced on Monday, 27th July, 2026 at 9:00 a.m. and ended on Wednesday, 29th July, 2026 at 5:00 p.m. Mr. Bhaskar Upadhyay, Practising Company Secretary of N L Bhatia & Associates, was appointed as Scrutinizer to scrutinize the voting process.

Record date for determining voting rights: Thursday, 23rd July, 2026

Total number of shareholders on record date: 481,440

Resolutions Passed

All ten resolutions proposed in the Notice dated 5th June, 2026 were passed with requisite majority:

Ordinary Business:

1. Adoption of Audited Financial Statements for FY 2025-26

  • Votes in favour: 99,24,89,842 (99.8320%)
  • Votes against: 16,70,281 (0.1680%)

2. Re-appointment of Mr. Peter DeYoung (DIN: 07152550) who retires by rotation

  • Votes in favour: 99,34,97,552 (99.9071%)
  • Votes against: 9,24,214 (0.0929%)

3. Re-appointment of Ms. Nathalie Leitch (DIN: 09557042) who retires by rotation

  • Votes in favour: 99,34,85,664 (99.9059%)
  • Votes against: 9,36,102 (0.0941%)

8. Ratification of remuneration payable to Cost Auditors for FY 2026-27

  • Votes in favour: 99,42,22,158 (99.9799%)
  • Votes against: 1,99,508 (0.0201%)

Special Business:

4. Re-appointment of Mr. Peter DeYoung as Whole-Time Director, designated as Executive Director

  • Votes in favour: 92,12,37,904 (92.6406%)
  • Votes against: 7,31,83,612 (7.3594%)

5. Re-appointment of Ms. Nandini Piramal (DIN: 00286092) as Whole-Time Director, designated as Executive Director and Chairperson

  • Votes in favour: 90,02,03,351 (90.5253%)
  • Votes against: 9,42,18,255 (9.4747%)

6. Re-appointment of Mr. Sridhar Gorthi (DIN: 00035824) as Independent Director

  • Votes in favour: 91,07,68,243 (91.5877%)
  • Votes against: 8,36,53,343 (8.4123%)

7. Re-appointment of Mr. Peter Stevenson (DIN: 09544706) as Independent Director

  • Votes in favour: 99,41,22,815 (99.9699%)
  • Votes against: 2,98,901 (0.0301%)

9. Issue of Non-Convertible Debentures on Private Placement Basis

  • Votes in favour: 98,93,97,431 (99.4950%)
  • Votes against: 50,21,825 (0.5050%)

10. Creation of pledge or security over shareholding in material subsidiaries and/or their assets

  • Votes in favour: 95,63,85,603 (96.1751%)
  • Votes against: 3,80,35,874 (3.8249%)

Shareholding Pattern and Voting Breakdown

Total outstanding shares: 133,134,8130

Total votes polled across all resolutions: Approximately 99.4-99.5 crore votes (74.69% of outstanding shares)

Promoter & Promoter Group:

  • Shares held: 463,324,672
  • Consistently voted 100% in favor of all resolutions

Public Institutions:

  • Shares held: 355,457,387
  • Showed significant dissent on director reappointment resolutions (4, 5, 6)

Public Non-Institutions:

  • Shares held: 512,566,071
  • Overwhelmingly supported all resolutions (>99.9% in favor for most)

Additional Proceedings

The Chairperson apprised Members regarding the Company's performance and key highlights of FY 2025-26. Members were given opportunity to ask questions and seek clarifications, which were addressed by the Chairperson.